Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical Guidelines

  • News

    Baricitinib combo for COVID-19 accelerates recovery, study shows

    December 14, 2020

    The combination is intended for patients who need supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation.

  • 1
    News

    One-third of critical illness survivors emerge from ICU with functional deterioration

    November 18, 2020

    One-third of patients who survived nonsurgical ICU admission had evidence of functional status decline.

  • News

    Consensus guidelines address inpatient diabetes technology

    October 29, 2020

    The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin dosing systems in the hospital setting.

  • News

    COVID-19: Thromboembolic events high despite prophylaxis

    October 27, 2020

    “Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”

  • 1
    News

    How do you manage common inpatient oncologic emergencies?

    October 26, 2020

    It is important that hospitalists be proficient in managing emergencies that can arise during the natural history of cancer.

  • News

    Unneeded meds at discharge could cause harm

    October 26, 2020

    The problem stems from a technology disconnect when patients are transferred from the ICU to the general population.

  • 1
    News

    Score predicts risk for ventilation in COVID-19 patients

    October 23, 2020

    “If mild COVID disease in young patients caused cardiac injury, you can imagine what it can do to older patients with severe disease,” Dr. Alnababteh said.

  • 1
    News

    Certain statins linked to lower mortality risk in patients admitted for sepsis

    October 22, 2020

    Statin use was associated with lower mortality, compared with no use, with hydrophilic and synthetic statins besting lipophilic and fungal-derived statins.

  • News

    Link between vitamin D and ICU outcomes unclear

    October 20, 2020

    When patients are admitted to the ICU, some biomarkers in the body are too high and others are too low. Vitamin D is often too low.

  • News

    Remdesivir effective, well-tolerated in final trial report

    October 9, 2020

    A 50% greater likelihood of significant clinical improvement within 15 days occurs with taking remdesivir versus placebo.

Previous1 … 10 11 12 13 14 … 41Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences